APSR2026-774

 
Regular
Submitted
Poster Presentation
 
AP12-014
P91
 
Format: PPTX Only
 
Format: PDF Only
16. Interstitial Lung Disease
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

DUSHANTHA MADEGEDARA * WAYAMBE UNIVERSITY MEDICINE KURUNAGALA Sri Lanka
DILKY RATHNAYAKE - WAYAMBE UNIVERSITY MEDICINE KURUNAGALA Sri Lanka
Harshani Eramudugolla - WAYAMBE UNIVERSITY MEDICINE KURUNAGALA Sri Lanka
PREVEEN JAYARATHNA - WAYAMBE UNIVERSITY MEDICINE KURUNAGALA Sri Lanka
-
-
-
-
-
-
-
-
-
-
-
Presenting Author Details
DUSHANTHA
MADEGEDARA
dhanukshi@classictravel.lk
+94765251144
61-70
Sri Lanka
Original Research
Infection as the primary driver of acute exacerbations in interstitial lung disease in a Sri Lankan tertiary care centre
Maximum 25 words
Abstract Content
<p>Acute exacerbations of interstitial lung disease (AE-ILD) are associated with significant morbidity and mortality, with limited data from South Asia. This study evaluated clinical characteristics, precipitating factors, and outcomes of AE-ILD in a Sri Lankan tertiary care setting.  </p>
<p>A prospective descriptive study was conducted among 50 adults with established ILD admitted with acute exacerbations to National Hospital Kandy (June 2025–January 2026). Data on demographics, ILD subtype, comorbidities, environmental exposures, clinical features, investigations, precipitating factors, treatment, and outcomes were collected using structured questionnaires and clinical records. Exacerbation severity was defined by ICU admission, ventilatory support, or in-hospital mortality. Patients were followed up for three months. Data were analysed using descriptive statistics and inferential tests (Chi-square and Fisher’s exact test).  </p>
<p>Among 50 patients, females predominated (74.0%, n=37), with most aged 61–80 years (60.0%, n=30). Non-IPF ILDs were most common, including unclassified ILD (44.0%, n=22) and CTD-ILD (38.0%, n=19). Comorbidities were present in 68.0% (n=34), particularly autoimmune disease (38.0%, n=19) and diabetes (28.0%, n=14). Environmental exposures were highly prevalent, including indoor air pollution (98.0%, n=49) and biomass fuel use (94.0%, n=47). Infective triggers predominated (78.0%, n=39), including pneumonia (50.0%, n=25) and viral infections (28.0%, n=14). Severe exacerbations occurred in 8.0% (n=4) and were significantly associated with hypersensitivity pneumonitis (p=0.020), diabetes (p=0.029), neutrophilia (p=0.018), lymphopenia (p=0.038), radiological consolidation (p=0.011), and respiratory failure (p<0.001). All patients received treatment; ICU admission occurred in 4.0% (n=2), non-invasive ventilation in 6.0% (n=3), and in-hospital mortality was 6.0% (n=3). At 3 months, functional recovery was observed, with improved exercise capacity in 72.0% (n=36) and normal lung function in 36.0% (n=18).  </p>
<p>AE-ILD in this cohort predominantly involved non-IPF disease and was most commonly infection-driven. Despite relatively low in-hospital mortality, targeted prevention of infections and environmental exposures, along with early recognition and management, may improve outcomes</p>
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Interstitial lung disease; Acute exacerbation; Outcomes
maximum 3 keywords and no abbreviations, separated by commas
none
345